drugset
drugset / Trial / NCT04890418

Risk Factors and Prevention of Severe Pain Upon Cessation of a Peripheral Nerve Block

NCT04890418 ↗

Phase 4 Unknown 100 enrolled Cliniques universitaires Saint-Luc- Université Catholique de Louvain
RandomizedParallel-groupTriple-blindTreatment

Summary

Risk factors and Prevention of severe Pain upon cessation of a peripheral nerve block. A prospective randomized study in ambulatory patients undergoing upper limb bone surgery under single shot axillary plexus block.

Timeline

Start
2020-01-01
Primary completion
2021-05-31
Completion
2021-07-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ketamine Small molecule 0.3 mg/kg Intravenous

Indications

No indication recorded.